NeoCore Technology Co., Ltd.

Research NeoCore Technology Co., Ltd. (4131.TWO) on Bullrun: market cap TWD 1.20B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is TWD 1.20B.

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18TWD 1.20Bn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 TWD.

About NeoCore Technology Co., Ltd.

NeoCore Technology Co., Ltd. designs, manufactures, and sells biochips and rapid nucleic acid hybridization devices. The company's products include food safety testing kits, including DR. Meat Kit, DR. Food-Ent kit, rapid test kit, and ELISA kit; infectious disease testing, such as DR. HPV Genotyping IVD Kit, DR. MTBC Screen IVD Kit, and DR. Microorganism IVD Kit (Non-sterile); and biochip instruments and equipment, including DR. AiM Reader, DR.Mini Oven, and DR.Fluidic Station.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is NeoCore Technology Co., Ltd.'s market cap?

NeoCore Technology Co., Ltd.'s market capitalization is TWD 1.20B.

What does NeoCore Technology Co., Ltd. do?

NeoCore Technology Co., Ltd. designs, manufactures, and sells biochips and rapid nucleic acid hybridization devices. The company's products include food safety testing kits, including DR. Meat Kit, DR. Food-Ent kit, rapid test kit, and ELISA kit; infectious disease testing, such as DR. HPV Genotyping IVD Kit, DR. MTBC Screen IVD Kit, and DR. Microorganism IVD Kit (Non-sterile); and biochip instruments and equipment, including DR. AiM Reader, DR.Mini Oven, and DR.Fluidic Station. In addition, the company engages in the wholesale and retail of contact lenses. The company was formerly known as DR.